Literature DB >> 3828215

Retrospective radiographic study of skeletal changes after long-term etretinate therapy.

B Melnik, S Glück, R M Jungblut, G Goerz.   

Abstract

Radiographic skeletal examinations were performed in eight adult patients who had received the aromatic retinoid etretinate for various disorders of keratinization over periods ranging from 1 to 7 years. Age- and sex-matched controls were also examined. In all patients, alterations of ossification were found to a varying degree, including calcification of the anterior spinal ligament, vertebral hyperostoses at the anterosuperior and anteroinferior margins of the vertebral bodies, unilateral bridging of vertebral bodies, hyperostoses of the calcanei at the insertion of the plantar ligament and bone accretion at the anterolateral lips of the acetabula. All the bone changes were asymptomatic. Serum calcium, inorganic phosphate, alkaline phosphatase, calcitonin and parathormone were within normal physiological ranges. In general, the bone changes observed after long-term etretinate treatment closely resembled the effects of isotretinoin on the skeleton.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3828215     DOI: 10.1111/j.1365-2133.1987.tb05813.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Case report: psoriatic erythroderma with bilateral osseous bridge across the acetabulum.

Authors:  Shigeyoshi Tsuji; Tetsuya Tomita; Masahiro Inaoka; Mari Higashiyama
Journal:  Clin Orthop Relat Res       Date:  2009-08-06       Impact factor: 4.176

Review 2.  Comparative tolerability of systemic treatments for plaque-type psoriasis.

Authors:  Stacy L McClure; Jayme Valentine; Kenneth B Gordon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Adverse effects of retinoids.

Authors:  M David; E Hodak; N J Lowe
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

4.  Acitretin : A Review of its Pharmacology and Therapeutic Use.

Authors:  Tania Pilkington; Rex N Brogden
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 5.  Epidermolytic hyperkeratosis: clinical update.

Authors:  Denice Peter Rout; Anushka Nair; Anand Gupta; Piyush Kumar
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.